 PLEASANTON, Calif., Jan. 08, 2021 GLOBE NEWSWIRE -- Natus Medical Incorporated NASDAQ:NTUS the Company or Natus, a leading provider of medical device solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages, today updated fourth quarter 2020 revenue guidance previously released October 29, 2020 and announced that Jonathan Kennedy, President and Chief Executive Officer will present at the virtual 39th Annual JP Morgan Healthcare Conference and virtual 23rd Annual Needham Growth Conference. 